Hospital de Base Researchers Update Current Study Findings on Cancer (Prescription pattern of abiraterone in Brazil - a survey of medical oncologists).

Abiraterone Acetate Therapy, Cancer, Cytochrome P450 17A1 Inhibitors, Drugs and Therapies, Health and Medicine, Oncology, Pharmaceuticals Keywords: Abiraterone Acetate Therapy; Cancer; Cytochrome P450 17A1 Inhibitors; Drugs and Therapies; Health and Medicine; Oncology; Pharmaceuticals EN Abiraterone Acetate Therapy Cancer Cytochrome P450 17A1 Inhibitors Drugs and Therapies Health and Medicine Oncology Pharmaceuticals 448 448 1 09/11/23 20230912 NES 230912 2023 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on cancer are discussed in a new report. Most prescribers were willing to use abiraterone acetate low-dose for patients from the public system, and 50% were already using abiraterone acetate-low dose in their practices. [Extracted from the article]

Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)